Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561-2569 [0.03%]
加尔韦斯-费南德斯等。尿锌与2型糖尿病发病：来自强心脏研究的前瞻性证据。《糖尿病治疗》2022年；45:2561-2569
Jingli Yang,Juwel Rana,Aimin Yang
Jingli Yang
Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475 [0.03%]
杜阿尔特等关于糖尿病神经痛电刺激系统评价和网络meta分析的述评《糖尿病护理》2022年第45卷2466-2475页
Ashwini D Sharan,John A Hatheway,Melissa Murphy et al.
Ashwini D Sharan et al.
Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137 [0.03%]
唐等关于碳酰化和贫血对糖尿病慢性肾脏病患者HbA1c与肾结局相关性影响的述评《糖尿病护理》2023年第46卷130-137页
Ninon Foussard,Alice Larroumet,Amandine Ferrière et al.
Ninon Foussard et al.
Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634-641 [0.03%]
Celis-Morales等关于2型糖尿病、血糖控制及其与痴呆及其主要亚型关联的研究评论回复《糖尿病护理》2022年；45卷：634-641页
Carlos A Celis-Morales,Bjorn Eliasson,Naveed Sattar
Carlos A Celis-Morales
Oriana Hoi Yun Yu,Samy Suissa
Oriana Hoi Yun Yu
The quest to repurpose metformin, an antidiabetes drug, as an agent for cancer prevention and treatment, which began in 2005 with an observational study that reported a reduction in cancer incidence among metformin users, generated extensiv...
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390 [0.03%]
关于Bezin等人的评论：GLP-1受体激动剂与甲状腺癌风险。Diabetes Care 2023;46:384-390
Ronald M Goldenberg,Akshay B Jain
Ronald M Goldenberg
Response to Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561-2569 [0.03%]
Diabetes Care：关于Galvez-Fernandez等的评论信——尿锌与2型糖尿病发病的关系：Strong Heart研究中的前瞻性证据
Marta Galvez-Fernandez,Ana Navas-Acien
Marta Galvez-Fernandez
Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634-641 [0.03%]
Celis-Morales等关于2型糖尿病、血糖控制及其与痴呆及其主要亚型关联的研究述评：来自瑞典国家糖尿病登记册的结果《糖尿病护理》2022年；45卷：634-641页
Xiaoni Meng,Youxin Wang
Xiaoni Meng
The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3 [0.03%]
Sotagliflozin对1型糖尿病患者心肾保护相关临床标志物的影响：inTandem3研究的事后探索性分析
Vikas S Sridhar,Hiddo J L Heerspink,Michael J Davies et al.
Vikas S Sridhar et al.